Dr. Hendrik Schneider

Senior Scientist for development of an innovative technology platform enabling targeted delivery of small molecule drugs.

Biochemistry, Antibody-drug-Conjugates, Enzymatic Bioconugation, Polysaccheride Modification, Peptide Synthesis, PNA Synthesis, RP-HPLC, ESI-MS, NMR, IR, HIC, SEC [1] Becker, B., Englert, S., Schneider, H., Journal of Peptide Science, 27(4): e3298. [2] Schneider, H, Frontiers in Chemistry 9 (2021): 518.

Biochemistry, Antibody-drug-Conjugates (High DAR), Polysaccheride Modification, Peptide Synthesis, PNA Synthesis, RP-HPLC, ESI-MS, NMR, IR, HIC, SEC Publications: [1] Schneider, Hendrik, et al., ChemistryOpen 8 (3), (2019): 354-357. [2] Schneider, Hendrik, et al., ChemBioChem 20 (24), (2019): 3006-3012. [3] Schneider, Hendrik, et al., Analytical Biochemistry (2020): 113615. [4] Baalmann, et al. ChemRxiv (2019). [5] Deweid et al., Chemistry–A European Journal, 24 (57), (2018): 15195-15200.

During my PhD, I additionally performed research for the Merck Lab @ TU Darmstadt. This interdisciplinary lab is a strategic partnership between Merck and the University, that focuses on the development of low-instrumented diagnostics and analytics.

Biochemistry, Antibody-drug-Conjugates (High DAR), Protein Modification, Peptide Synthesis, PNA Synthesis, ESI-MS, RP-HPLC, IR, NMR, HIC, SEC

CGC Catalysators, SHOP-type Catalysators, HDPE, Polymer Synthesis

SPPS, Buliding-Bloc synthesis, Water-soluble Protected Amino Acids, Sulfonati